Sandbox: Difference between revisions
Jump to navigation
Jump to search
Undo revision 647248 by Ujjwal Rastogi (talk) |
No edit summary |
||
| Line 1: | Line 1: | ||
<a name="top"></a> | |||
[[Sandbox#Antiretroviral drug toxicities and quality of life|testing]] | [[Sandbox#Antiretroviral drug toxicities and quality of life|testing]] | ||
| Line 46: | Line 46: | ||
==Social== | ==Social==<a href="#top">TOP OF PAGE</a> | ||
addOnloadHook(function() { elems = document.getElementsByClassName('editsection'); for (i = 0; i < elems.length; i++) elems[i].innerHTML = '[<a href="#top">Back to top</a>] ' + elems[i].innerHTML; }); | addOnloadHook(function() { elems = document.getElementsByClassName('editsection'); for (i = 0; i < elems.length; i++) elems[i].innerHTML = '[<a href="#top">Back to top</a>] ' + elems[i].innerHTML; }); | ||
Revision as of 04:59, 27 May 2012
<a name="top"></a> testing
- ===Antiretroviral drug toxicities and quality of life===
- PI
- PI
Earlier initiation of ART extends exposure to ARV agents by several years. The D:A:D study found an increased incidence of CVD associated with cumulative exposure to some drugs in the nucleoside reverse transcriptase inhibitor (NRTI) and PI drug classes.
==Social==<a href="#top">TOP OF PAGE</a>
addOnloadHook(function() { elems = document.getElementsByClassName('editsection'); for (i = 0; i < elems.length; i++) elems[i].innerHTML = '[<a href="#top">Back to top</a>] ' + elems[i].innerHTML; });